Related Experiment Video
Updated: Jun 24, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statins impair CD1d-mediated antigen presentation through the inhibition of prenylation
Masood A Khan1, Richard M Gallo, Gourapura J Renukaradhya
1Department of Microbiology and Immunology, Indiana University School of Medicine, Walther Oncology Center, Indianapolis, IN 46202, USA.
Abstract:
Statins are widely used as cholesterol-lowering agents that also decrease inflammation and target enzymes essential for prenylation, an important process in the activation and intracellular transport of proteins vital for a wide variety of cellular functions. Here, we report that statins impair a critical component of the innate immune response, CD1d-mediated Ag presentation. The addition of specific intermediates in the isoprenylation pathway reversed this effect, whereas specific targeting of enzymes responsible for prenylation mimicked the inhibitory effects of statins on Ag presentation by CD1d as well as MHC class II molecules. This study demonstrates the importance of isoprenylation in the regulation of Ag presentation and suggests a mechanism by which statins reduce inflammatory responses.
Insights
Statins impair CD1d-mediated antigen presentation, a key part of the innate immune response. Restoring isoprenylation intermediates reversed this effect, highlighting prenylation's role in immune function.
Area of Science:
- Immunology
- Cellular Biology
- Pharmacology
Background:
- Statins are cholesterol-lowering drugs with anti-inflammatory properties.
- Statins target enzymes involved in prenylation, crucial for protein activation and transport.
- Prenylation is vital for diverse cellular functions and immune responses.
Purpose of the Study:
- To investigate the impact of statins on antigen presentation.
- To elucidate the role of prenylation in CD1d-mediated antigen presentation.
- To explore the mechanism by which statins modulate immune responses.
Main Methods:
- Assessing the effect of statins on CD1d-mediated antigen presentation.
- Utilizing specific intermediates of the isoprenylation pathway.
- Targeting enzymes responsible for prenylation.
- Evaluating antigen presentation by both CD1d and MHC class II molecules.
Main Results:
- Statins were found to impair CD1d-mediated antigen presentation.
- Addition of isoprenylation pathway intermediates reversed the statin-induced impairment.
- Targeting prenylation enzymes mimicked statins' inhibitory effects on antigen presentation.
- Both CD1d and MHC class II antigen presentation were affected.
Conclusions:
- Isoprenylation is critical for regulating antigen presentation.
- Statins interfere with antigen presentation by inhibiting prenylation.
- This study provides a mechanism for statin-mediated reduction of inflammatory responses.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inhibition of CDK Activity
Inhibition of Cdk Activity
Inhibitors of Virion Maturation and Assembly
Regulation of Nuclear Protein Sorting
Inhibitors of Viral Protein Synthesis
